Week 6 - An Intractable Problem Flashcards

1
Q

What is pharmacodynamics?

A

The effect of the drug on the body

e.g. What are the changes in the body after taking this drug? (lower BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the definition of absorption as part of ADME?

A

Process by which drug moves from its site of administration to the systemic circulation

Via:
- Passive diffusion
Lipophilic drugs: cross membrane ‘transcellular’

Hydrophilic drugs: Low molecular weight hydrophilic drugs, pores and gap junctions

  • Active transport (large molecular weight drugs, ATP-dependent transporter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is pharmacokinetics?

A

The effect of the body on the drug

e.g. How does body respond to the drug? ADME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List FOUR pieces of information which are found on a medical license

2 marks

A

The licence for a medicine includes information such as: (Any for ½ mark each)
· What health condition it should be used to treat
· What dose should be used
· What form it takes – such as a tablet or liquid
· Who can use the medicine – for example, only people above a certain age
· How long treatment with that medicine should last
· Warnings about known safety issues – such as side effects and interactions with other medicines
· How the medicine should be stored
When the medicine expires

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain why the binding of a competitive antagonist to a receptor is a reversible process?

2 marks

A

A competitive antagonist binds to the same binding site as an agonist. (1/2 mark)

If the concentration of agonist is increased it will replace the binding of the antagonist (1/2 mark) and this will lead to a full tissue response (1/2 mark).

Hence, the antagonism is said to be reversible (1/2 mark).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the main route for oral drug absorption?

A

Passive diffusion via the transcellular pathway

This occurs through enterocytes (simple columnar epithelial cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define the term ‘therapeutic window’.

1 mark

A

The therapeutic window is the range of drug doses (or drug concentration in the plasma) that produces a therapeutic response without causing significant adverse response (side effects) in the patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the journey of a drug through the body?

A

Drug at site of administration

  • ABSORPTION -

Drug in plasma

  • DISTRIBUTION -

Drug at target organs/tissues

  • METABOLISM -

Metabolites in tissues

  • ELIMINATION -

Drug or metabolites in urine/faeces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name the cell type involved in the transcellular pathway which allows oral drugs to be absorbed across the intestine (1/2 mark) AND name one type of membrane transport system in this pathway. [1/2mark]
1 mark

A

Enterocytes or absorptive cells (1/2 mark)

Any one of the following:
Simple (passive) diffusion

OR carrier-mediated transport
OR active transport (1/2 mark).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What proteins can a drug interact with?

A

Receptor
Ion channel
Enzyme
Carrier molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the different types of receptors?

A

Ligand-gated channels
GPCRs
Enzyme-linked receptors
Intracellular receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the definition of distribution under ADME?

A

The reversible transfer of a drug to and from the systemic circulation

The drug has to be unbound (not bound to plasma proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do drugs bind to?

A

Proteins in the blood plasma like human serum albumin, lipoproteins, glycoproteins, alpha, beta and gamma globulins

Only unbound drugs can be distributed, metabolised or excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What percentage of a drug is usually unbound to plasma proteins?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the definition of metabolism in ADME?

A

Any chemical alteration of a drug by the living system to enhance water solubility and hence excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the definition of excretion of metabolism in ADME?

A

The irreversible transfer of a drug from the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Besides binding to its target, what other properties must an oral drug have in order to exert its maximum effect in the body?

A

Dissolve

Survive a range of pHs (1.5 - 8.0)

Survive intestinal bacteria

Survive liver metabolism

Partition into target organ (get to the receptors where it is needed)

Cross membranes

Avoid excretion by kidneys

Avoid active transport to bile

Avoid partition to non-target organ (in undesired places e.g. brain or foetus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What happens in the Pre-Clinical Testing of a drug?

How long does this usually last?

A

Use cells and tissues in culture to test the general effects of the drug (in at least 2 species)

Tests for any potentially life-threatening, deleterious effects

Lasts on average 18 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What happens Phase 0 of clinical trials?

A

First time the drug is given to humans (a small group of 10 healthy individuals)

First time pharmacodynamics and pharmacokinetics can be observed in vivo

Checks for any harmful, unforeseeable side effects of the trialed drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What happens in Phase I of the Clinical Trial?

A

Still healthy volunteers
Higher cohort

Dose escalation study is implemented to determine the appropriate dosage required to produce the desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What happens in Phase II of a Clinical Trial?

A

First time actual patients with the condition the drug is supposed to be for are involved

Few hundred participants are given placebo or actual drug

Assess the effectiveness of the new drug by subtracting the placebo’s efficacy from trialled drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What happens in Phase III of a clinical trail?

A

Similar to phase II

Several thousands of patients

Increases the reliability of the data

Benefits of the new drug are weighed against side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What occurs in Phase 4 of the drug trailing process?

A

Continous testing and review of the effects of the drug as it is being marketed and sold to the public

Patients can feedback about the effects of the drug to appropriate bodies through the yellow card scheme put in place by the MHRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the MHRA?

A

Medicines and Healthcare Products Regulatory Agency (MHRA)

The government body that approves and regulates drugs used in healthcare in the UK

Yellow card scheme allows patients to report problems with a drug after it is on the market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How long is a patent in the UK?

A

20 years

Can be extended for another 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How long does it take for a drug to come to market?

A

12.5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How much does it take for a drug to come to market?

A

£1,150 million

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is a drug patent?

A

When one company are the only company to make a drug and charge quite high prices for it

Generic versions of a drug then can be made when a patent has ended, they are a lot cheaper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Give an example of a receptor that is a drug target

A

Receptor

e.g. intracellular oestrogen receptor (Tamoxifen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Give an example of an ion channel that is a drug target

A

Na+ ion channels (Analgesics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Give an example of an enzyme that is a drug target

A

Bacterial topoisomerases (Quinolones - antibiotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Give an example of a carrier molecule that is a drug target

A

Na+ K+ 2Cl- symporter (Loop diuretics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Where does excretion usually take place? (ADME)

A

Occurs primarily from the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Give an example of a ligand gated ion channel

A

Nicotinic acetylcholine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Give an example of G protein coupled receptors

A

Muscarinic acetylcholine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Give an example of enzyme-linked receptors

A

HER2

Tyrosine Kinase Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Give an example of intracellular receptors

A

Oestrogen receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How do ligand gated ion channels work?

A

Activated and then sodium ions etc go through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

How do G protein coupled receptors work?

A

Target binds
G protein is recruited (alpha, beta and gamma subunit)
GDP changed to GTP

The alpha subunit gets phosphorylated and detaches

The phosphorylated alpha subunit then interacts with a downstream protein (e.g. cAMP)

Creates downstream signalling cascades and
2nd Messengers e.g. opening ion channel

GTP is then hydrolysed back to GDP and the signal stops (the alpha subunit binds to GDP and switches the signal off)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the affinity of a drug?

A

How strongly a drug binds to its target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How do intracellular receptors work?

A

Also known as nuclear receptors

Transport to the nucleus and activates transcription and translation signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is the efficacy of a drug?

A

The ability of a drug to have its ideal effect in ideal conditions (e.g. randomised control trials)

‘The maximum response achievable from a pharmaceutical drug in research settings and to the capacity for sufficient therapeutic effect or beneficial change in clinical settings’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What do agonists do?

A

Bind and activates receptors

Usually neurotransmitters/ hormones

Useful when there is not enough signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is a full agonist?

A

Produces the maximal possible signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is a partial agonist?

A

Produces a less than maximal signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is an antagonist?

A

Something that blocks receptor activation

Has affinity but no efficacy

Blocks the effects of neurotransmitters/ hormones

Useful when there is too much signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is a competitive antagonist?

A

Competes for binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is a non-competitive antagonist?

A

Blocks effect through a different binding site (allosteric), different mechanism (physiological), direct interaction with drug molecule (chemical)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Describe the activation of a GPCR

A

In the resting state, the GPCR is linked to an enzyme called a G protein

When a ligand binds to a G-protein coupled receptor, the G protein is activated and GDP is converted to GTP

This in turn activates downstream signals

The G protein is switched off by the hydrolysis of GTP to GDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

How exactly does Tegaserod increase peristalsis in the colon?

A

5-HT4 receptor is found in the colon and its activation by Tegaserod stimulates release of neurotransmitters involved in peristalsis which are Acetylcholine and nitric oxide

This increases the rate of peristalsis

This decreases visceral sensitivity and reduces pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is an inverse agonist?

A

Decreases the ongoing level of signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What 2 neurotransmitters are involved in peristalsis? What receptor is activated to release them?

A

Acetylcholine
Nitric oxide

5-HT4 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What is the action of tubocurarine?

A

Antagonist

Muscle relaxant for surgery

Working on ligand-gated sodium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What is the action of atropine?

A

Antagonist

Inhibits the parasympathetic nervous system - decreases heart rate and saliva

Works on G Protein Coupled Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What is the action of FP-1039?

A

Antagonist

Cancer therapy (development)

Works on tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is the action of Tamoxifen?

A

Antagonist

Breast cancer treatment

Works on nuclear receptors, oestrogen receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Where are G-protein coupled receptors found?

A

They are found with the membrane

Transmembrane regions

58
Q

What neurotransmitters activate G-protein coupled receptors?

A

Acetylcholine
Serotonin
Noradrenaline

Hormones

59
Q

What percentage of human drug targets are G-protein coupled receptors?

A

27%

60
Q

What type of receptor is the 5-HT 4 receptor?

A

GPCR

61
Q

What are G proteins made up of?

A

An alpha, beta and gamma subunit

62
Q

Which subunit of a G protein detaches?

A

Alpha

63
Q

What is 5-HT4 receptor also known as?

A

Serotonin type 4 receptor (UK)

5 Hydroxy-tryptonine receptor (USA)

64
Q

Is Tegaserod an agonist or antagonist? What type?

Where is its receptor found?

A

Partial agonist
High affinity

5-HT4 receptor is found in the colon

65
Q

Which part of the body is pharmacokinetics and ADME and which part of the body is pharmacodynamics in?

A

ADME and Pharmokinetics are at the same time when the drug enters and body tries to metabolise and excrete it etc

You see how much concentration is left in the plasma

Pharmacodynamics is from the plasma into the site of action, and you see the effect of the drug on the body and the concentration that is left at the site of action that is actually necessary

66
Q

At the site of action, what 2 things does the drug need to be in order for it to be clinically useful?

A

In sufficient quantity

For suitable duration

67
Q

How does ADME influence drug design?

A

How much of a dose is needed is effect by:

  • How quickly it gets to the site of action
  • How soluble the drug is
  • Avoiding overdose
  • How quickly it metabolises
68
Q

What nerves do you have in the GI tract?

A

Inside the GI tract you have the enteric nervous system inside the wall localised primarily in the myenteric plexus and submucosal plexus

You also have the autonomic nervous system with sympathetic (‘fight or flight’) and parasympathetic (‘rest or digest’)

Sympathetic: Heart rate and breathing rate increases, blood directed away from ‘non essentials - i.e. the gut’ and moves towards the heart and muscles for fast action - inhibits digestion

Parasympathetic: Relaxed, gastrointestinal secretion and motility increase

The enteric nervous system has parasympathetic and sympathetic inputs and can work independently of them too

69
Q

What are the two main plexuses of the enteric nervous system?

A

Submucosal (Meissner’s)

Myenteric (Auerbach’s)

70
Q

What exactly is the enteric nervous system?

A

The enteric nervous is the peripheral extension of the autonomic nervous system that is capable of some independent function

It has both sympathetic and parasympathetic inputs

71
Q

When was the enteric nervous system established as a separate functional part of the nervous system?

A

1970s

72
Q

How does the parasympathetic stimulation promote what it does?

A

Vagal stimulation increases the tone of the intestinal wall and increases the rate of peristalsis

Increases digestion and absorption

73
Q

How does the sympathetic stimulation cause what it does?

A

Reduces peristalsis and tone but does not abolish them

Also increases tone in several sphincters delaying movement of gut contents

74
Q

When does peristalsis cease?

A

Only if the submucosal and myenteric plexuses in the gut wall are paralysed

Peristalsis continues even if all the nerves to the gut are cut (parasympathetic or sympathetic)

75
Q

What is the primary neurotransmitter in the enteric nervous system?

A

Acetylcholine

76
Q

What are the different neurotransmitters in the enteric nervous system?

A
Acetylcholine
Noradrenaline
GABA
Nitric oxide
Serotonin
77
Q

What do the peripheral autonomic nervous pathways contain?

A

Pre-ganglionic and post-ganglionic neurons

78
Q

What is the small intestine made of?

A

Duodenum
Jejunum
Ileum

79
Q

What is the large intestine made of?

A

Cecum (pouch)
Colon (ascending, transverse, descending)
Rectum

80
Q

What muscles are involved in peristalsis?

A

Longitudinal and circular muscles

81
Q

How do drugs usually cross membranes in oral absorption?

A

Passive diffusion of lipophilic drugs through the membrane - transcellular pathway (main route for most oral drugs)

Passive diffusion of hydrophilic drugs, through pores and gap junctions between the cells (paracellular, there are usually water channels in between cells)
Low molecular weight

Also have active transport of large molecules by transport proteins (e.g. glucose and amino acids)
Requires energy.

82
Q

What determines the speed at which a drug crosses membranes?

A

Size of the drug

Lipophilicity of the drug (physiochemical properties)

83
Q

What does transcellular pathway mean?

A

Through the membrane

84
Q

What does paracellular pathway mean?

A

Junctions between the cells (water channels, pores, gap junctions)

85
Q

What is the function of goblet cells?

A

Secreting mucus

86
Q

What factors affect absorption?

A

Acid stability - stable in acidic stomach conditions (pH1) and then absorb in neutral small intestine conditions (ph7)

Solubility - drug requires sufficient aqueous solubility for dissolution (can only absorb something that is dissolved)

Permeability - poor permeability, gut wall metabolism/efflux can lead to poor absorption across the intestinal wall (disease, ulcers can affect this)

Lipophilicity - if goes through cell wall needs to be lipophilic enough but polar enough to be sufficiently water soluble

87
Q

What is the main plasma protein that drugs bind to?

A

Albumin

88
Q

What is the route for the drug to take?

A
In
ABSORPTION
Blood
DISTRIBUTION
Tissues
89
Q

What drugs can be distributed?

A

Unbound drugs

Unbound to plasma proteins

90
Q

What percentage of the drug usually binds to plasma proteins?

A

98%

91
Q

What percentage of the drug is free for binding to the target?

A

2%

92
Q

How does the blood from the stomach, small intestine and large intestine get to the liver?

A

Hepatic portal vein

93
Q

What is Phase I (first pass metabolism)?

A

When new polar groups on the drug are added on by oxidation, reduction and hydrolysis reactions

This is so the drug would be more polar and water soluble to then be more easily degraded and excreted

Makes Phase II reactions more likely

94
Q

What family of enzymes undertakes oxidation in Phase I metabolism?

A

Cytochrome p450

95
Q

What types of drugs usually undergo Phase I metabolism?

A
Warfarin
Anti-depressants
Anti-epileptics
Statins
Codine
96
Q

What happens in Phase II metabolism?

A

The drug becomes larger, more polar, more water soluble

One of the following molecules are added on: ‘conjugated’

  • glutathione
  • sulphate
  • glucornide

Makes it more likely for the drug to be excreted by the kidneys and eliminated

Hepatic and renal checks are often done before giving patients drugs

97
Q

What molecules are added in Phase II metabolism?

A
  • glutathione
  • sulphate
  • glucornide
98
Q

What types of reactions happen in Phase I metabolism?

A

Hydrolysis

Oxidation

99
Q

What types of reactions happen in Phase I metabolism?

A

Conjugation

100
Q

What are the main points around Renal Excretion?

A
  • all unbound drug in plasma is filtered in the glomerulus (very polar compounds only)
  • some compounds are actively secreted into the urine along the proximal tube
  • unionised drug can undergo passive reabsorption from urine into blood along the length of nephron (so net excretion is zero - important to note in dosing)
  • drug that is bound to plasma proteins is not filtered
101
Q

What is the PKPD relationship?

Define each and then state how they work together

A

Pharmacokinetics - the effect of the body on the drug

Pharmodynamics - the effect of the drug on the body

Relationship:
The potential for the drug to have its desired effect (PD) before the drug is metabolised and eliminated from the body (PK)

Understanding this helps with figuring out doses, frequencies etc

102
Q

What are factors that can affect the PKPD ?

A

Clinical status

Nutritional status

Co-administration of two or more drugs

Gender

Weight

Patient’s age

103
Q

What is the concentration that is required for a drug to work called?

A

Minimum effective concentration (MEC)

104
Q

What is the concentration that may caused side effects/toxicity called?

A

Maximum tolerated concentration (MTC)

105
Q

What does a standard plasma concentration/time profile look like?

A

See graph in powerpoint

Draw out

106
Q

Explain why the plasma concentration of a drug/time profile has the curve it does?

A

Essentially ADME

The drug is absorbed and enters the blood stream, concentration rises

Compound distributes into tissues and absorption rates start to slow down

Drug is metabolised and excreted from the systemic circulation

107
Q

In principle, how does the body see drugs?

A

It sees it as toxic and foreign

So it will try and eliminate it asap

108
Q

What is the steady state concentration?

A

In the PKPD relationships and looking at the plasma concentration/time profiles

Steady state concentration is basically when the drug concentrations is starting to drop, you time your dosing and give the patient another dose, to boast the drug concentration a little bit to make it stay in the therapeutic window

109
Q

What is the therapeutic window?

A

The range of drug doses (or drug concentration in the plasma) that produces a therapeutic effect

110
Q

What are the different stages of the drug discovery process?

A

Target selection (condition/ disease/ target chosen)

Target validation (is the target the right target, if inhibited/activated does it do what you want it to do?)

Load discovery (High throughput screening to find what compounds interacts with the target)

Load optimisation (several molecules are chosen, drug is optimised, chemists will change the chemistry of the drug to make it have higher or lower affinity for the receptor, more acidic/basic)

Preclinical development (will it kill you? in vitro and in vivo models)

Clinical development (side effects)

Regulatory approval (convince others)

111
Q

When do patents begin?

A

Right at the beginning of the process at target selection

So will have 20 year patents, and 5 years left of their patent to make their money back

112
Q

What fraction of compounds entering preclinical development?

A

1/13 compounds

113
Q

How many compounds enter the Drug Discovery stage?

A

10,000

114
Q

How many compounds enter Pre-clinical trials?

A

250

115
Q

What type of cells are enterocytes?

A

Simple columnar epithelial cells

116
Q

How many compounds enter clinical trials?

A

5

117
Q

How many drugs are FDA review?

A

1

118
Q

When was the Medicines and Healthcare Regulatory products Agency (MHRA) formed?

A

2003?

119
Q

What is the function of the MHRA?

A

Regulation of clinical trials

Assessment and authorisation of medicinal products in the UK

Operates post-marketing drug surveillance

120
Q

When was the EMA formed?

A

1993

121
Q

What does the EMA stand for?

A

European Medicines Agency

122
Q

What does MHRA stand for?

A

Medicines and Healthcare Regulatory products Agency

123
Q

What are the functions of the EMA?

A

Coordinates the evaluation and supervision of the new medicinal products

Grants opinion on licensing and oversees pharmacovigilance

(Pharmaceuticals as well as medical devices)

124
Q

What does FDA stand for?

A

Food and Drug Administration

In the US

125
Q

When was the FDA established?

A

1927

126
Q

What are the functions of the FDA?

A

Responsible for regulation and supervision of drug safety

Drug assessment, authorisation, post-marketing surveillance

127
Q

Who can report concerns about medicines and devices with the Yellow Card Scheme?

A

Healthcare professionals and the general public

128
Q

What can you report with the Yellow Card Scheme?

A
  • Side effects (adverse drug reactions or ADRs)
  • Medical devices adverse incidents
  • Defective medicines of poor quality
  • Counterfeit or fake medicines or medical devices
  • Safety concerns for e-cigarettes or their refill containers (e-liquid)
129
Q

What membranes might a drug have to cross if orally absorbed?

A

Enterocytes in the GI tract

Epithelial cells that line the tissues/organs

130
Q

Explain the basics of clinical trials

A

Phase 0 - Lab to human

Phase I - Small group of healthy volunteers, evaluate safety of the new treatment (10s)

Phase II - Larger group and in people with condition being targeted (100s) (efficacy, renal function, hepatic function, cardiac problems)

Phase III - Larger scale (1000s) (dosage, effects on different populations, toxicity, double blind, match patients for disease, age sex etc)

Phase IV - Post marketing, adverse reaction reports

131
Q

What is a double blind clinical trial?

A

Scientists and patients don’t know if they are taken the drug or control/ current treatment

132
Q

Why is a double blind clinical trials important

A

Biased

133
Q

What is the new drug that has replaced Tegaserod?

A

5 HT-4 receptor agonist called prucalopride (Shire Pharmaceuticals) approved for use in Europe for constipation in females

EMA approved this compound after extensive demonstration of cardiac safety

Not many of these drugs on the market at all

134
Q

Where does peristalsis happen?

A

Oesophagus
Stomach
Intestines

135
Q

Why was Tegaserod taken off the market?

A

Withdrawn for increased risk of heart complications

Tachycardias and arrhythmias

136
Q

How is Tegaserod linked to the heart?

A

The 5-HT4 receptor in the colon is its main target

There are similar receptors in the heart, causing increased contractions

137
Q

What is intractable constipation?

A

Constipation that is prolonged and does not resolve with the usual therapeutic measures

138
Q

What type of receptor is a 5-HT4 receptor?

A

G Protein Coupled Receptor

140
Q

What is Tegaserod?

A

Selective partial agonist that binds with high affinity to 5-HT4 receptors in the colon

Stimulates the peristaltic reflex and intestinal secretion

Thus promoting gastric emptying and prevents constipation

141
Q

What is Tegaserod?

A

A 5-HT4 agonist used for the management of IBS and constipation

141
Q

How does Tegaserod increase peristalsis?

A

5-HT4 receptors

These receptors are located in the colon on motor nerves

When the 5-HT4 receptors are activated, they facilitate release of transmitters involved in peristalsis (ACh and NO)

This increases the rate of peristalsis

Also decreases the colon’s sensitivity and reduces the pain